Enigma Diagnostics

Tecan will manufacture Enigma's new point-of-care molecular diagnostic instrument under a five-year deal.

Pairings

Premium

Chris Wagner, Brad Popovich, Jorge Garces, Greg Hamilton, Nick Williams, Darren Hall

The British molecular diagnostics firm also announced executive appointments for both the US and European operations.

The firms will develop tests to run on Enigma's ML platform. As part of the alliance, GSK will make an equity investment in the molecular diagnostics startup.

Enigma Diagnostics gained access to two Roche patents for use in its multiplex PCR tests for human and animal diseases.

In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

Pages

Researchers report using genotyping to tie together illegal ivory shipments and trace them back to a handful of cartels, the New York Times reports.

Researchers find that historical factors influence which genes are the most highly studied, the Atlantic reports.

The US National Science Foundation's new sexual harassment policy is to go into effect next month, according to Nature News.

In Nature this week: genomic ancestry analysis of Sardinians, current noncoding mutations in colorectal cancer, and more.